|
|
|
40
|
43314
|
GLIVEC 100MG CAP (NVS/COL) IMATINIB
|
IMATINIB
|
GLIVEC
|
60'S
|
C
|
2,478.40
|
41.31
|
CAPSULE
|
0
|
CAP
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
43314
|
GLIVEC 100MG CAP (NVS) IMATINIB (BQ)
|
IMATINIB
|
GLIVEC
|
60'S
|
BQ
|
2478.4
|
41.3067
|
CAP
|
120
|
BOX
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
42
|
43314
|
GLIVEC 100MG CAP (NVS) IMATINIB
|
IMATINIB
|
GLIVEC
|
60'S
|
BQ
|
2,478.40
|
41.31
|
CAP
|
120
|
BLIS
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
AVENTA BARBADOS
|
|
1000
|
ANTINEOPLASTICS
|
2026-04-01
|
|
|
ORAL
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
4331AA
|
APO-IMATINIB 100MG TAB (APO/COL)
|
IMATINIB
|
APO-IMATINIB
|
30'S
|
BQ
|
33.84
|
1.13
|
TABLET
|
0
|
TAB
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
42
|
4331AD
|
IMATINIB DENK 100MG TAB (EDK)
|
IMATINIB
|
IMATINIB DENK
|
30'S
|
BQ
|
1,291.20
|
43.04
|
TAB
|
120
|
BLIS
|
EDK
|
DENK PHARMA GMBH & CO. KG.
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
1000
|
ANTINEOPLASTICS
|
2026-04-01
|
|
|
ORAL
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
4331BA
|
APO-IMATINIB 100MG TAB (APO) IMATIN (BQ)
|
IMATINIB
|
APO-IMATINIB
|
30'S
|
BQ
|
34.52
|
1.1508
|
TAB
|
120
|
BOX
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
4331BB
|
ZIMITIB 100MG CAP (ZUV) IMATINIB (BQ)
|
IMATINIB
|
ZIMITIB
|
120'S
|
BQ
|
61.76
|
0.5147
|
CAP
|
120
|
BOX
|
ZUV
|
ZUVIUS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2024-05-17
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
2024-04-05
|
|
|
|
41
|
4331BD
|
ZIMITIB 100 CAP (ZUV) IMATINIB
|
IMATINIB
|
ZIMITIB
|
30'S
|
BQ
|
47.68
|
1.5893
|
TAB
|
|
BOX
|
ZUV
|
ZUVIUS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-05
|
2026-03-31
|
|
ORAL
|
|
ANTINEOPLASTICS
|
2024-04-05
|
|
|
|
40
|
43321
|
GLIVEC 400MG CAP (NVS/COL) IMATINIB
|
IMATINIB
|
GLIVEC
|
30'S
|
C
|
4,599.40
|
153.31
|
CAPSULE
|
0
|
CAP
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
43321
|
GLIVEC 400MG CAP (NVS) IMATINIB (SAD) (BQ)
|
IMATINIB
|
GLIVEC
|
30'S
|
BQ
|
4568.74
|
152.2914
|
CAP
|
60
|
BOX
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
42
|
43321
|
GLIVEC 400MG CAP (NVS) IMATINIB (SAD)
|
IMATINIB
|
GLIVEC
|
30'S
|
C
|
4,568.74
|
152.29
|
CAP
|
60
|
BLIS
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
AVENTA BARBADOS
|
|
1000
|
ANTINEOPLASTICS
|
2026-04-01
|
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
42
|
43327
|
IMATINIB 400MG CAP (ZUV)
|
IMATINIB
|
IMATINIB
|
30'S
|
BQ
|
32.02
|
1.07
|
CAP
|
60
|
BLIS
|
ZUV
|
ZUVIUS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
1000
|
ANTINEOPLASTICS
|
2026-04-01
|
|
|
ORAL
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
4332K
|
APO-IMATINIB 400MG TAB (APO/COL)
|
IMATINIB
|
APO-IMATINIB
|
30'S
|
BQ
|
123.96
|
4.13
|
TABLET
|
0
|
TAB
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
4332U
|
TYKONIB 400MG TAB (MSN) (BQ)
|
IMATINIB
|
TYKONIB
|
30'S
|
BQ
|
117.02
|
3.9008
|
TAB
|
60
|
BOTT
|
MSN
|
MSN LABS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
4332Y
|
APO-IMATINIB 400MG CAP (APO) (BQ)
|
IMATINIB
|
APO-IMATINIB
|
30'S
|
BQ
|
125.21
|
4.1735
|
CAP
|
60
|
BOX
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|